https://www.europeanpharmaceuticalreview.com/first-treatment-approval-for-advanced-asps/178071.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-imaweld-heat-sealable-and-weldable-tube-bioprocess-media/178078.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/first-patient-enrolled-in-cisplatin-induced-ototoxicity-phase-ii-trial/178102.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/janssen-submits-marketing-application-for-bispecific-antibody/178109.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/wuxi-sta-opens-its-first-oral-solids-continuous-manufacturing-line/178136.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/gileads-6585m-immunotherapy-collaboration/178150.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-validates-enhertu-type-ii-variation-application-for-lung-cancer/178158.article 2026-03-05T17:01:46.577Z https://www.europeanpharmaceuticalreview.com/first-in-class-telomerase-inhibitor-aids-transfusion-independence-in-clinical-trial/178171.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/moderna-to-obtain-first-acquisition-for-85-million/178187.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/case-study-expedite-microbial-contamination-investigations/178188.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/fda-accepts-biologics-license-application-for-rsv-vaccine/178198.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ebook-extractables-and-leachables-a-guide-to-analytical-methods/178202.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-biontechs-new-partnership-accelerate-personalised-mrna-therapy-trials/178232.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/gsk-to-pay-40-million-to-license-multiple-t-cell-engagers/178254.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-grants-priority-review-of-glofitamab-for-lymphoma/178267.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/major-manda-deals-on-2023-agenda-says-report/178313.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-grants-accelerated-approval-for-leqembi/178331.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/astrazeneca-to-acquire-cincor-in-nearly-2b-deal/178338.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/inprocess-lsp/178344.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/potential-blockbuster-drugs-to-watch-in-2023/178363.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pharmapack-europe-to-launch-two-new-zones-in-2024/178373.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/promising-first-in-human-study-results-for-orally-inhaled-antibiotic/178380.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/eisai-submits-maa-for-lecanemab-in-europe/178399.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/is-machine-learning-the-answer-for-long-acting-injectable-drugs/178405.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/gut-microbiome-key-in-parkinsons-suggests-study/178411.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pharmaceutical-microbiology-key-developments-2022/178422.article 2026-03-31T14:12:31.220Z https://www.europeanpharmaceuticalreview.com/ec-approves-influenza-antiviral-for-children-over-one-years-old/178475.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/2022-terra-carta-seal-three-pharma-companies-awarded/178490.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ph-eur-adopts-revised-general-monographs-after-adding-paragraph-on-n-nitrosamines/178501.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pre-filled-asthma-pen-approved-for-self-administration-in-eu/178513.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/t-cell-therapy-helps-overcome-stem-cell-transplant-viral-infections/178519.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-approves-long-acting-injectable-for-schizophrenia-and-bipolar-disorder/178542.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/switzerland-and-us-sign-drug-inspection-agreement/178559.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/moderna-joins-the-association-of-the-british-pharmaceutical-industry/178576.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/potential-treatment-identified-for-septic-patients/178595.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/mhra-approves-biosimilar-for-vision-disorders-in-great-britain/178605.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/uk-atmp-clinical-trials-report-2022-published/178617.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/uk-medical-cannabis-manufacturer-granted-gmp-registration/178640.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/mrna-vaccine-trial-shows-efficiency-in-older-adults-with-rsv/178651.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pfizer-offers-12-billion-in-poorer-countries-access-to-full-medicine-portfolio/178662.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/nice-recommends-all-oral-treatment-for-multiple-myeloma/178699.article 2026-03-06T13:09:03.317Z https://www.europeanpharmaceuticalreview.com/amgen-commits-8m-to-clinical-trial-diversity-programme/178712.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/clinical-trial-first-for-liver-cancer-immunotherapy-combo/178720.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/mhra-authorises-brukinsa-in-great-britain-for-two-cancers/178748.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ebook-nanoparticle-formulations-overcoming-dissolution-challenges/178753.article 2026-03-31T14:12:31.220Z https://www.europeanpharmaceuticalreview.com/fda-issues-complete-response-letter-for-donanemab/178756.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/limiting-microbial-hazards-in-inhaled-cannabis-products/178765.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/personalised-cancer-immunotherapy-granted-fast-track-designation/178798.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/eu-antibiotic-shortages-being-monitored-by-mssg/178811.article 2026-03-06T16:31:07.623Z https://www.europeanpharmaceuticalreview.com/onivyde-improves-survival-in-phase-iii-pancreatic-cancer-trial/178817.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/takeda-to-license-potential-treatment-for-colorectal-cancer/178838.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/largest-global-clinical-site-hires-all-female-key-leaders-in-europe/178848.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-validates-first-regulatory-submission-for-crispr-based-medicine/178870.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/major-study-on-dmt-shows-promise-for-depression/178880.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/who-urges-supply-chain-to-take-action-on-contaminated-medicines/178891.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-publishes-updated-qanda-for-ich-m10/178910.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-car-t-cell-therapy-recommended-on-nhs/178922.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/enhertu-approved-in-eu-for-her2-low-breast-cancer/178941.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-uk-point-of-care-manufacturing-regulatory-framework/178955.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/eli-lilly-to-help-fund-cold-chain-initiative/178962.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/monoclonal-antibody-could-prevent-malaria-study-shows/178968.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/chmp-meeting-highlights-january-2023/179004.article 2026-03-06T13:09:03.317Z https://www.europeanpharmaceuticalreview.com/key-developments-mrna-vaccines-and-therapeutics/179010.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-approves-first-btk-inhibitor-for-lymphoma/179016.article 2026-03-06T13:09:03.317Z https://www.europeanpharmaceuticalreview.com/citrate-free-hcf-of-adalimumab-biosimilar-gets-positive-opinion/179021.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/virtual-reality-training-in-pharma-just-a-headset-away/179036.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/poster-how-to-choose-the-right-titration-electrodes/179041.article 2026-03-06T13:09:59.960Z https://www.europeanpharmaceuticalreview.com/three-year-patent-strategy-for-greater-medicine-access-announced/179045.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-medicine-approved-in-eu-for-eosinophilic-esophagitis/179054.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pharmaceutical-sterility-testing-market-to-grow-from-207b-in-2027/179072.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/clinical-trials-information-system-mandatory-in-eu/179088.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/halting-europes-essential-medicines-manufacturing-exodus/179121.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pharmapack-europe-awards-2023-winners-announced/179132.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-rapid-adoption-of-medication-adherence-and-smart-packages-key-factors-driving-interest-and-consideration/179147.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-biosimilar-to-humira-available-in-us/179151.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/mhra-approves-first-oral-advanced-therapy-for-crohns-disease/179158.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/five-potential-eu-regulatory-changes-impacting-the-life-sciences-industry-in-2023/179203.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/france-gets-new-sterile-liquid-drug-manufacturing-facility/179214.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/abpi-warns-against-revenue-clawback-rate-rises/179225.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/video-understanding-current-regulatory-thinking-on-contamination-control-strategy/179226.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/pembrolizumab-plus-chemo-improves-endometrial-cancer-survival/179236.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-in-class-therapy-shows-potential-for-chronic-fibrosis/179255.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/bms-in-licensed-pkc-theta-inhibitor-enters-clinical-trials/179265.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/msd-and-nectin-to-collaborate-on-clinical-trial-for-keytruda-combination/179282.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/forxiga-approved-in-eu-for-chronic-heart-failure/179288.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-gives-first-rmat-designation-to-a-cardiac-gene-therapy/179315.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cd19-car-t-agents-to-boost-blood-cancer-market/179320.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novel-two-chamber-setup-could-predict-hpapi-dustiness/179342.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-oral-difelikefalin-be-first-fda-approved-drug-for-notalgia-paresthetica/179356.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pierre-fabre-to-lead-commercialisation-of-ebvallo/179361.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/astellas-and-bayer-announce-management-changes/179377.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cgt-catapult-to-bolster-new-uk-life-sciences-campus/179389.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pfizer-and-biontech-mrna-shingles-vaccine-study-begins/179432.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/car-t-cell-therapy-offers-substantial-remission-rates-in-trial/179443.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/analytical-platform-could-advance-mrna-medicine-qc/179454.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/medicinal-cannabis-the-route-to-good-manufacturing-practice-registration/179459.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/johnson-and-johnson-appoints-new-executive-vice-president-pharmaceuticals-randd/179477.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/hpapi-global-market-to-reach-3404b-in-2026/179486.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/using-alkali-metal-cation-recognition-of--cyclodextrin-to-detect-lithium-ions-by-maldi-tof/179487.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/neoadjuvant-nivolumab-improves-long-term-survival-for-lung-cancer/179511.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/genentech-to-open-new-high-tech-biologics-facility/179528.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-1-2023/179568.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-commission-awards-77-million-to-mechanochemistry-project/179571.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/analytical-techniques-in-depth-focus-2023/179581.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/lonza-completes-bioconjugation-facility-expansion/179587.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/endotoxin-trends-sustainability-automation-and-beyond/179610.article 2026-03-10T10:00:23.623Z https://www.europeanpharmaceuticalreview.com/fusion-to-acquire-radiologand-therapy-for-prostate-cancer/179611.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/optimising-fermentation-with-process-analytical-technology/179625.article 2026-03-08T18:46:11Z https://www.europeanpharmaceuticalreview.com/enzyme-replacement-therapy-for-alpha-mannosidosis-gets-fda-approval/179634.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-releases-human-medicines-highlights-2022-report/179640.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/shining-a-light-on-raman-for-microbiological-analysis/179658.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/challenges-in-pharmaceutical-microbiology-looking-to-the-future/179674.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/2022-uk-life-sciences-recruitment-report-revealed/179676.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/moving-towards-oral-delivery-of-biologics/179695.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/peracetic-acid-uv-light-treatment-could-improve-microbial-water-quality/179715.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ec-approves-first-gene-therapy-for-haemophilia-b/179732.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-approves-first-treatment-for-geographic-atrophy/179738.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/identifying-bacterial-isolates-to-help-prevent-cleanroom-contamination/179757.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pda-releases-contamination-control-strategy-report/179766.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/astrazeneca-btk-inhibitor-tablet-approved-in-eu-for-leukaemia/179773.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/article-the-importance-of-real-time-nanoparticle-size-analysis/179782.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/developing-terminal-sterilisation-processes-for-oligonucleotide-drugs/179793.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/accelerating-drug-development/179807.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/upc-opt-out-a-strategic-balancing-act-for-pharma/179819.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/simplified-hiv-treatment-options-effective-in-major-trial/179835.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ph-eur-rabbit-pyrogen-test-replacement-texts-ready-for-public-consultation/179846.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-rapid-identification-of-polysorbates-20-and-80-through-amber-bottles/179861.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-designing-an-environmental-monitoring-solution-for-gmp/179874.article 2026-03-10T09:52:35.220Z https://www.europeanpharmaceuticalreview.com/imfinzi-plus-imjudo-approved-in-eu-for-advanced-cancers/179876.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-gas-analysis-mass-spectrometer-applications-in-fermentation-and-cell-culture-process/179883.article 2026-03-08T08:20:57.120Z https://www.europeanpharmaceuticalreview.com/taking-advantage-of-protein-charge-properties-for-challenging-separations/179891.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-successful-car-t-treatment-for-muscle-inflammation/179917.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/collaboration-to-support-quality-production-of-biologics/179928.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/vitiligo-treatment-gets-positive-chmp-opinion/179940.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/bioavailability-enhancement-services-market-to-exhibit-11-percent-cagr/179969.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/product-hub-rapid-mold-detection-in-as-little-as-one-day/179975.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/chmp-recommends-first-pegylated-enzyme-for-fabry-disease/179980.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/overcoming-barriers-to-capturing-data-in-a-laboratory/179996.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cell-therapy-first-for-chronic-heart-failure/180003.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/product-hub-how-can-aseptic-manufacturers-prevent-losses-in-the-millions/180009.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/product-hub-bioprocess-monitoring-made-simple-with-ramina-process-analyzer/180015.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/product-hub-gmp-ready-ultrapure-water-passcode-access-validation-support-and-toc-verification/180029.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/immunotherapy-before-surgery-benefits-melanoma-patients/180040.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/nitrosamines-where-now/180043.article 2026-03-08T19:04:13.483Z https://www.europeanpharmaceuticalreview.com/whitepapers/brochure-the-caliber-manufacturing-suite-caliberbrm/180052.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/new-workflow-for-the-analysis-of-mrna-therapeutics/180078.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/prioritising-for-a-data-driven-2023/180104.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/computed-tomography-for-in-depth-investigation-of-freeze-dried-products/180117.article 2026-03-06T16:07:18.827Z https://www.europeanpharmaceuticalreview.com/uk-partnership-set-to-revolutionise-oligonucleotide-manufacture/180176.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/press-release-biopharmaceutical-testing-capabilities-increasing-in-switzerland/180178.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-purification-method-could-enhance-protein-drug-manufacturing/180200.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/emas-human-medicines-committee-chmp-meeting-highlights-february-2023/180223.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/enhancing-bioavailability-formulations-containing-soluble-acidic-drugs/180231.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/learning-from-lecanemab-a-breakthrough-treatment/180242.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-working-party-to-address-excipients-in-ph-eur-monographs/180271.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pharma-responds-to-uk-government-statutory-scheme-rise/180277.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/moderna-chooses-mrna-vaccine-manufacturing-centre-location/180316.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/temperature-stable-tuberculosis-vaccine-induces-immune-response/180326.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/combination-therapy-significantly-improves-pulmonary-hemodynamics/180336.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/handling-hpapis-safely-what-does-it-take/180352.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pistoia-alliance-launches-pharma-innovation-council/180364.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/leading-in-pharma-a-womans-pathway/180374.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/oral-pcsk9-inhibitor-substantially-reduces-cholesterol-study-finds/180397.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-cell-therapy-company-will-treat-solid-tumours/180402.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/natural-allopregnanolone-made-orally-bioavailable/180410.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/parallel-import-of-medicinal-products-regulatory-update/180418.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-nasal-monoclonal-antibody-covid-19-treatment-shows-potential/180437.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-default-eligibility-improve-clinical-trial-enrolment/180458.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-nhs-cell-and-gene-therapy-centre-opens/180477.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/enhancing-bioavailability-in-ocular-drug-delivery/180489.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/injectable-peptide-rapidly-reduces-intracranial-pressure/180508.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/sandoz-to-build-biologics-plant-in-slovenia/180522.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/gut-microbiome-linked-to-cancer-car-t-therapy-response/180531.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/smc-accepts-treatment-for-chronic-hepatitis-delta-virus/180542.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pfizer-to-acquire-seagen-for-43-billion/180551.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/mass-spectrometry-software-can-link-different-data-types/180586.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novel-small-molecule-drug-facilitates-leukaemia-remission/180602.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/dual-cystic-fibrosis-modulator-therapy-shows-efficacy-in-four-year-study/180632.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-mixed-race-woman-potentially-cured-of-hiv/180640.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-fcrn-blocker-approved-in-uk-for-myasthenia-gravis/180692.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/gosh-and-leucid-to-manufacture-novel-car-t-therapy/180699.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/mhra-to-trial-stem-cell-robot-for-cell-therapies/180733.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novartis-releases-long-term-data-for-sma-gene-therapy/180780.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/biontech-to-jointly-develop-novel-antibody-for-cancers/180791.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/mhra-approves-prostate-cancer-combination-therapy/180797.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/kite-releases-pivotal-car-t-therapy-phase-iii-study-results/180811.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cphi-pharma-awards-marks-20th-anniversary/180826.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/identifying-origin-of-fungi-in-cleanrooms/180833.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/collaboration-to-produce-3d-screen-printed-pharmaceuticals/180845.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-dupixent-be-the-first-biologic-to-treat-copd/180864.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-gene-therapy-recommended-for-aadc/180872.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/takeda-to-build-600m-plasma-therapy-manufacturing-site/180879.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/developing-novel-therapies-for-nash/180887.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-mild-asthma-combination-reliever-approved-in-uk/180910.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-publishes-mid-point-regulatory-science-strategy-report/180916.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/nasal-spray-for-depression-shows-long-term-efficacy/180947.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/rapid-microbiology-testing-market-growth-expected-2022-to-2027/180959.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-biologics-manufacturing-facility-gets-1b-investment/180981.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-in-class-plaque-psoriasis-oral-therapy-approved-in-eu/180992.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-immunotherapy-recommended-for-advanced-cervical-cancer/181030.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novel-delivery-approach-demonstrates-efficacy-of-immunotherapy/181065.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/277m-investment-to-advance-uk-life-sciences-manufacturing/181072.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/gsk-to-exclusively-license-novel-oral-antifungal/181081.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/biopharma-could-reap-benefits-from-svb-uk-acquisition/181096.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/innovative-mass-spectrometry-method-facilitates-accurate-c-auris-identification/181109.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/generic-manufacturers-sign-sublicences-to-produce-long-acting-hiv-medicine/181116.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ilap-improving-access-to-innovative-oncology-treatments/181123.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/chmp-meeting-highlights-march-2023/181147.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/treatment-shows-strong-potential-for-alk-driven-neuroblastoma/181161.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/pdf-unique-non-invasive-pat-tool-for-nanoparticle-analysis/181175.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/monoclonal-antibodies-can-lower-covid-19-hospitalisation-risk/181185.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-reducing-agar-concentration-enhance-microbial-growth/181199.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cgt-supply-chain-and-logistics-market-worth-312b-by-2031/181229.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/psychedelic-medicines-are-they-gaining-traction-in-europe/181261.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/eculizumab-biosimilar-gets-positive-chmp-opinion/181281.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/nice-guidance-recommends-olaparib-for-breast-and-prostate-cancers/181293.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/sustained-release-chemotherapy-has-potential-for-bladder-cancer/181308.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/a-review-of-maldi-tof-for-microbiological-identification/181341.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/microbial-fermentation-tech-market-to-exceed-569b-by-2033/181358.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/turning-the-tide-oligonucleotide-development-trends/181376.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/personalised-blood-pressure-treatment-shows-efficacy/181405.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/biogen-to-develop-amyloid-beta-targeting-antibody-platform/181420.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/interphex-2023-experience-science-through-commercialisation/181440.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/can-automated-buffer-management-systems-overcome-bioprocessing-bottlenecks/181458.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/navigating-delivery-challenges-of-nucleic-acid-therapeutics/181489.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/merck-to-develop-mab-through-108b-acquisition/181527.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/combination-therapy-facilitates-optimal-stem-cell-collection/181535.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/automation-to-accelerate-biopharma-in-next-decade/181543.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/gsk-to-acquire-bellus-for-16-billion/181560.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/eli-lilly-promises-additional-16b-manufacturing-investment/181570.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-atr-ft-ir-spectroscopy-become-gold-standard-for-heparin-analysis/181595.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/electronic-smart-packaging-market-to-value-nearly-3b-in-2033/181606.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-approves-allogeneic-stem-cell-transplant-therapy/181618.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pharma-within-planetary-boundaries/181639.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/oral-drug-reduces-treatment-resistant-migraine-frequency/181669.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-approves-first-new-b-cell-lymphoma-treatment-in-20-years/181686.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/what-gene-therapy-manufacturers-can-gain-from-collaboration/181719.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-2-2023/181736.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/realising-the-potential-of-aav-gene-therapies/181742.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/bioprocessing/bioproduction-in-depth-focus-2023/181753.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/guide-to-testing/181758.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/innovating-pharma-at-the-edge/181767.article 2026-03-08T18:39:08.993Z https://www.europeanpharmaceuticalreview.com/nice-recommends-therapy-duo-for-advanced-leukaemia/181782.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/yescarta-demonstrates-promising-european-manufacturing-experience/181812.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/injectable-small-molecule-inhibitor-could-improve-vision/181820.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/why-randd-innovation-holds-the-key-to-greater-patient-impact/181829.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/boehringer-ingelheim-invests-350m-in-new-biotech-randd-facility/181845.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/monoclonal-antibody-combination-treatment-given-nice-approval/181877.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pioneering-malaria-vaccine-gains-regulatory-clearance/181884.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novartis-releases-data-for-potentially-practice-changing-pnh-medicine/181900.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/modernas-mrna-vaccine-manufacturing-centre-begins-construction/181939.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/immunotherapy-to-become-standard-treatment-for-infants-with-all/181951.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/biologic-could-be-first-new-hidradenitis-suppurativa-treatment-in-a-decade/181980.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/bristol-myers-squibb-appoints-new-ceo/181988.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-enhancing-microbial-monitoring-with-an-online-bioburden-analyser/182036.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/pharma-responds-to-proposed-eu-pharmaceutical-legislation-reform/182041.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/product-hub-introducing-a-new-era-in-hplc/182044.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/global-research-consortium-to-help-address-antimicrobial-resistance/182060.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/transforming-oncology-with-antibody-therapeutics/182074.article 2026-03-31T14:12:31.220Z https://www.europeanpharmaceuticalreview.com/bristol-myers-squibb-boosts-car-t-therapy-manufacturing-capabilities/182102.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/astellas-to-accelerate-ocular-disease-treatments-with-59-billion-acquisition/182143.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/press-release-sgs-wins-business-leadership-award-2023/182164.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-releases-draft-guidance-for-decentralised-clinical-trials/182174.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novel-device-opens-blood-brain-barrier-to-deliver-chemotherapy/182192.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-commission-approves-car-t-therapy-for-lymphoma/182199.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/digital-transformation-to-drive-biomanufacturing-market/182207.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-rsv-vaccine-approved-for-older-adults/182233.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-to-review-ctis-transparency-rules/182259.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/mit-unlocks-real-time-powder-particle-size-distribution-monitoring/182284.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/enzyme-replacement-therapy-approved-for-fabry-disease/182300.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/realising-milestones-with-gene-therapy-for-sma/182332.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/can-glp-1-obesity-therapy-restore-nk-cell-function/182365.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/antibody-response-varies-for-big-pharma-covid-vaccines/182374.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/sandoz-to-boost-biosimilar-development-with-manufacturing-expansion/182396.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/launching-revvity-a-scientific-solutions-company-powering-innovation-from-discovery-to-cure/182409.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-publishes-paper-on-ai/ml-in-drug-development/182445.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/17b-acquisition-to-develop-rare-haematology-therapy/182467.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-personalised-mrna-vaccine-be-first-for-cancer/182474.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/rwe-shows-efficacy-of-nirsevimab-for-infant-rsv/182505.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/recent-developments-in-stem-cell-therapies/182527.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ai-driven-biosimilar-manufacturing-partnership-announced/182556.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/intratumoural-viral-delivery-improves-glioblastoma-survival/182602.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/digitalisation-to-boost-quality-management-systems-market/182615.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-treatment-conditionally-licensed-for-chronic-hepatitis-d/182624.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-guidance-aims-to-prevent-medicine-shortages/182655.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/nice-recommends-rinvoq-for-crohns/182662.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-fda-recommend-new-antibiotic-for-hospital-acquired-pneumonia/182678.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-nice-recommended-treatment-for-chronic-heart-failure/182691.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/survey-reports-untapped-potential-for-uk-clinical-trials/182724.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/benefits-of-blockchain-in-limiting-counterfeit-drug-distribution/182737.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/machine-learning-can-predict-outcomes-for-inkjet-printed-pharmaceuticals/182756.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/press-release-sgs-launches-sgs-pace-a-streamlined-pathway-through-preclinical-formulation-fih-and-poc/182759.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-biotechs-choosing-switzerland-as-base-research-shows/182768.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-redosable-gene-therapy-approved/182795.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/altasciences/182809.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/five-proposed-biosimilars-planned-for-development-in-europe/182813.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/scientific-journal-planning-your-first-in-human-trial/182815.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/research-outlines-framework-for-robotic-laboratory-automation/182825.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pharmapack-awards-2024-entries-open/182841.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/video-optimise-continuous-manufacturing-using-prosolv-easytab/182861.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/nanoparticle-hiv-vaccine-shows-potential-in-trial/182887.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/overcoming-bottlenecks-in-the-advanced-therapy-supply-chain/182901.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/life-sciences-sector-to-receive-650-million-funding/182936.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-recognition-routes-to-fast-track-uk-medicine-access/182952.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/chmp-meeting-highlights-may-2023/182992.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/automation-to-guide-technology-shift-in-aseptic-environments/183014.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-commission-approves-haematology-biosimilar/183025.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-lipid-based-nanoparticles-manufacturing-and-inline-size-characterisation/183040.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/big-pharma-inventory-management-trends-revealed/183076.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/crispr-based-microbial-gene-therapy-delivers-promise/183090.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/microfluidic-device-detects-bacteria-concentration-from-small-sample-volumes/183097.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/nice-recommends-oral-migraine-treatment-for-first-time/183142.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/the-cell-and-gene-therapy-cdmo-bottleneck-isnt-capacity-its-capability/183153.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-uk-drug-delivery-centre-to-support-rna-therapeutic-development/183175.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/sandoz-to-move-headquarters-to-basel-switzerland/183184.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novel-pat-system-could-enable-adaptive-process-control/183195.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/nivolumab-plus-chemo-provides-one-year-pfs-in-94-percent-lymphoma-patients/183232.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/analysis-reports-nitrosamine-prevalence-in-small-molecule-drugs/183246.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/study-identifies-key-contamination-source-during-atmp-manufacture/183256.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-amr-certification-launched-for-antibiotic-manufacturers/183286.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/small-molecule-treatment-reduces-risk-of-death-by-half-in-nsclc/183296.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-quality-requirements-for-tobacco-products/183315.article 2026-04-02T08:46:22.693Z https://www.europeanpharmaceuticalreview.com/cell-and-gene-therapy-catapult-opens-new-laboratories/183338.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/how-can-biopharma-strengthen-its-resilience/183346.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/edqm-publishes-annual-report/183356.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/biopharma-struggling-to-find-talent-with-adequate-digital-skills/183384.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novel-nanofiltration-method-for-microbial-biosurfactant-downstream-processing/183393.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/video-high-adhesion-coating-tablet-with-vivacoat-a/183395.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/international-regulation-the-importance-of-quality-assurance-in-drug-development/183412.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/radiopharma-production-facility-opens-in-belgium/183427.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pfizer-and-samsung-biologics-ink-biosimilars-manufacturing-deal/183432.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-novel-gene-therapy-treat-sickle-cell-disease/183441.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-approves-new-cell-therapy-manufacturing-plant/183483.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novo-nordisk-invests-21bn-in-hillerød-manufacturing-expansion/183490.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/scientific-journal-reduce-cns-drug-development-timelines-by-up-to-40/183511.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/25b-acquisition-to-boost-novartis-renal-portfolio/183521.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/worlds-largest-lutetium-177-production-site-opens/183529.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/chikungunya-vaccine-demonstrates-99-percent-immune-response/183546.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/case-study-eliminating-contamination-with-whole-genome-sequencing/183556.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/uk-medicines-manufacturing-must-remain-domestic/183567.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/61-percent-cagr-expected-for-pharmaceutical-sterility-testing-market/183575.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/why-is-microbiological-testing-in-medical-device-manufacturing-important/183593.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/randd-innovation-advancing-small-molecule-innovator-cdmo-market/183605.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/digitalisation-of-the-clinical-trial-landscape/183625.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-approves-off-the-shelf-bispecific-antibody-cancer-therapy/183650.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/how-can-ai-be-best-harnessed-for-pharmacovigilance-data/183663.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-novel-robotic-oral-pill-replace-traditional-injections/183693.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/how-effective-is-nanopore-sequencing-for-fungal-identification/183703.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/amr-certification-recognising-responsibly-in-antibiotic-manufacture/183716.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-in-class-oral-small-molecule-trial-data-presented-at-2023-era-congress/183723.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-adult-anti-inflammatory-cardiovascular-drug-approved/183741.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/protak-scientific-limited/183742.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/video-an-introduction-to-protak-scientific-and-enzyme-indicators-for-advanced-gaseous-bio-decontamination-validation/183752.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/video-the-route-to-faster-microbial-qc-with-the-milliflex-rapid-system-20/183765.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-mass-spec-technique-identified-for-electron-ionisation-direct-analysis/183768.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/reflecting-on-five-years-of-quality-control-for-nitrosamine-impurities/183778.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-approach-for-small-molecule-nanosimilar-analysis-reported/183803.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinar-a-rational-approach-to-excipient-selection-for-solid-dose-formulation-and-development/183813.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/reducing-bioburden-testing-and-sterility-testing-volumes-for-gene-therapies/183816.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-3-2023/183817.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-first-in-human-solutions-for-small-and-large-molecules/183819.article 2026-03-06T16:07:18.827Z https://www.europeanpharmaceuticalreview.com/gene-therapy-approved-for-duchenne-muscular-dystrophy/183862.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinar-how-crucial-is-culture-media-selection-in-environmental-monitoring-a-roundtable-discussion/183869.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/recommendations-and-considerations-for-bacteriophage-therapy-usage-in-clinical-settings/183871.article 2026-03-06T13:09:59.960Z https://www.europeanpharmaceuticalreview.com/first-rna-car-t-therapy-autoimmunity-trial-shows-potential/183875.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/titanium-dioxide-e171-and-its-role-in-formulation/183882.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/how-can-real-world-evidence-support-regulatory-decision-making/183921.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/the-future-of-medical-cannabis-development-in-europe/183928.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/tak-755-trumps-plasma-based-therapy-trial-shows/183931.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-publishes-recommendations-on-psychedelic-clinical-trial-design/183938.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/microbiome-therapies-a-maturing-movement/183944.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/lonza-and-vertex-to-partner-to-manufacture-diabetes-cell-therapies/183970.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fmf-world-congress-2023-janssen-shares-new-data-in-hdfn/183987.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/the-power-of-rapid-methods-for-fungal-id/183996.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/alzheimers-vaccine-granted-fast-track-designation/184000.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/formulation-in-depth-focus-2023/184009.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/hplc-market-projected-to-value-8-million-by-2030/184015.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-obicetrapib-facilitate-sufficient-ldl-cholesterol-levels/184031.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/uk-trial-to-test-psilocin-based-drug-for-major-depressive-disorder/184038.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/re-engineering-proteins-to-develop-novel-immunotherapies/184041.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/in-depth-focus-qa/qc-microbiology/rmm-2023/184044.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/preparing-for-stricter-standards-on-substances-of-human-origin/184053.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/guide-to-data-integrity/184056.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/capsule-formulation-future-trends/184060.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/on-the-clock-a-collaborative-approach-to-advancing-adoption-of-rmm/184078.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/eli-lilly-ulcerative-colitis-antibody-drug-doubles-remission-rates/184091.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-ai-generated-small-molecule-drug-enters-phase-ii-trial/184106.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-cell-therapy-approved-for-type-1-diabetes/184114.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-gene-therapy-approved-for-haemophilia-a/184130.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/global-pat-market-expected-to-exceed-10b-in-2032/184145.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/regenerative-potential-cellbased-therapies-for-heart-failure/184185.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-releases-analysis-on-drug-product-quality-in-2022/184193.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-small-molecule-medicine-treat-rare-liver-disease/184203.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/iso-publishes-standard-on-bacterial-endotoxin-testing/184224.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/novel-oral-therapy-shows-potential-in-plaque-psoriasis/184233.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-commission-extends-approval-of-cystic-fibrosis-medicine/184267.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/pda-revises-report-on-glass-container-manufacturing/184286.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/digitalising-hplc-methods-the-path-to-interoperability/184288.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/clinical-research-organisation-market-anticipated-to-reach-140bn-by-2033/184303.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/biontech-to-support-trial-access-for-cancer-immunotherapies/184319.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/sustainable-pharmaceuticals-what-about-pine-based-painkillers/184334.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/innovation-key-for-boosting-uk-biopharma-competitiveness/184342.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/innovative-pat-based-filtration-strategy-reported-for-continuous-biomanufacturing/184365.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/could-faecal-transplants-improve-melanoma-immunotherapy/184376.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-revises-guidance-on-nitrosamine-impurities/184457.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/video-the-eu-annex-1-good-manufacturing-process-gmp-updated-requirements/184470.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-accelerate-the-development-of-your-small-molecule/184472.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/bispecific-antibody-approved-in-europe-for-dlbcl/184475.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/wuxi-biologics-proposes-spin-off-to-support-bioconjugate-development/184485.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/post-approval-randd-key-in-advancing-oncology-treatments/184491.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ifpma-reveals-new-ceo-leadership-lineup/184504.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/safety-analysis-published-for-c-diff-biotherapeutic/184520.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/who-prequalifies-meningitis-conjugate-vaccine/184529.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ten-minute-subcutaneous-injection-shows-promise-for-ms/184566.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/how-can-pat-help-advance-biologics-manufacturing/184572.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/roche-agrees-to-develop-oncology-small-molecule-inhibitor/184589.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/report-highlights-trends-in-the-aseptic-fill-finish-market/184596.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/nih-spending-for-drugs-approved-2010-2019-lower-than-industry-spending-study-finds/184638.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-continuous-mrna-manufacturing-platform-to-be-developed/184650.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-data-suggests-novel-mab-could-delay-progression-of-early-alzheimers/184655.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/qms-market-to-value-nearly-4b-by-2030/184676.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/beyfortus-approved-for-us-infants-against-rsv-disease/184683.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/strengthening-and-transforming-the-pharmaceutical-supply-chain/184698.article 2026-03-06T16:31:07.623Z https://www.europeanpharmaceuticalreview.com/efficacy-of-novel-drug-proven-in-mdd-study/184722.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-prepares-for-winter-antibiotic-shortages/184732.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/the-evolution-of-aavs-in-cell-and-gene-therapy/184749.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/autonomous-pat-with-digital-twin-integration-reported/184760.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/genentech-to-reveal-new-data-for-ocular-biologic/184768.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-key-biomarkers-of-immunomodulation/184775.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/ema-seeks-public-opinion-on-ai-in-drug-development/184791.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/determining-accurate-estimation-of-true-endotoxin-concentration/184798.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/sandoz-to-build-slovenian-biosimilar-development-facility/184802.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/roche-to-co-develop-hypertension-rnai-therapeutic/185060.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/will-esr1-mutated-breast-cancer-treatment-gain-approval/185066.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/establishing-quality-assurance-in-personalised-preparations/185073.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/small-molecule-api-market-to-value-2847-billion-by-2032/185097.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novel-antibody-therapeutic-demonstrates-potential-in-gvhd/185103.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-ckd-treatment-option-approved-in-eu/185134.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/finnish-manufacturing-facility-to-get-50m-expansion/185141.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/adc-demonstrates-meaningful-survival-data-for-her2-cancers/185151.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-epiq-solution-brief/185175.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/innovative-solid-state-storage-for-biologics-developed/185187.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/approval-expanded-for-generalised-myasthenia-gravis-medicine/185201.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/astrazeneca-appoints-new-evp-of-biopharmaceuticals-randd/185220.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novel-pill-could-aid-postpartum-depression-symptoms/185230.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/paper-reports-on-qbd-in-bilayer-tablet-development/185239.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/biogen-to-acquire-rare-disease-drugmaker-for-73b/185285.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cdkl5-deficiency-associated-seizure-treatment-approved-in-eu/185292.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/innovation-passport-designation-awarded-to-pfizer-and-arvinas/185315.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-immuno-oncology-treatment-approved-for-endometrial-cancer/185325.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/accelerating-biomanufacturing-with-automated-pat-systems/185352.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-benefits-of-liquid-filled-capsules-for-pharmaceutical-development/185357.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/mhra-authorises-new-covid-19-vaccine/185371.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/treating-alzheimers-regulatory-hurdles-in-an-anti-amyloid-revolution/185404.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/harnessing-continuous-improvement-in-the-capa-process/185422.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-european-monograph-for-cannabis-flower-adopted/185437.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/adalimumab-biosimilars-shaping-market-research-states/185452.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/next-gen-sustainable-inhalers-on-the-horizon/185460.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-hiv-drug-formulation-could-transform-paediatric-administration/185469.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/antibiotic-manufactured-via-continuous-flow-for-first-time/185516.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/first-oral-medicine-for-postpartum-depression-approved/185526.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/astellas-to-advance-oncology-car-t-therapy/185533.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/new-vaccine-development-centre-to-strength-uks-capabilities/185554.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/astrazenecas-tezepelumab-and-dapagliflozin-accepted-for-use-in-scotland/185559.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/semaglutide-demonstrates-cardiovascular-benefit/185568.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/atrag-formulations-for-lung-disease/185584.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/adc-oncology-therapy-market-to-value-over-36b-by-2029/185606.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/will-novartis-provide-new-oral-option-for-chronic-hives/185612.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/novo-nordisk-makes-1-billion-acquisition-agreement/185625.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-warning-letters-highlight-capa-concerns/185633.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/multiple-myeloma-bispecific-antibody-granted-accelerated-approval/185640.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/european-commission-revokes-marketing-authorisation-for-novartis-crizanlizumab/185654.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cdmo-expands-cgt-manufacturing-site-in-italy/185694.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/fda-approval-for-janssens-prostate-cancer-treatment/185708.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/lilly-completes-biopharma-acquisitions/185712.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/buccal-drug-delivery-market-to-reach-71b-by-2030/185718.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cphi-to-return-to-milan-in-2024/185724.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/uk-approval-for-pompe-disease-therapy/185751.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/sandoz-to-file-for-approval-of-aflibercept-biosimilar/185771.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/abbvie-gains-eu-migraine-treatment-approval/185791.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/cdmo-to-manufacture-sars-cov-2-intranasal-vaccine/185800.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/immunotherapy-combo-could-overcome-melanoma-anti-pd-1-resistance/185806.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/chmp-to-review-maa-for-geographic-atrophy-treatment/185826.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/biopharma-sees-strong-q2-2023-market-cap-growth/185864.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-navigating-nitrosamine-impurity-testing/185872.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/global-rna-therapy-clinical-trials-market-to-reach-35-billion-by-2030/185873.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-are-nitrosamines-a-concern-for-biologic-manufacturers/185882.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/uk-medicines-manufacturing-to-get-innovation-boost/185893.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/webinar-altasciences-unique-project-management-offering/185896.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-sustainable-microbial-monitoring/185900.article 2026-03-10T10:00:23.623Z https://www.europeanpharmaceuticalreview.com/news/pfizer-maternal-rsv-vaccine-approved/185906.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/ai/ml-to-drive-bioprocess-containers-market/185921.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-therapeutic-shows-potential-in-thyroid-cancer/185944.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/proposed-non-animal-derived-reagent-chapter-published/185949.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/divest-to-invest-the-new-normal-in-biopharma/185959.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/report-accelerate-the-rmm-validation-process/186001.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/gsk-shingles-vaccine-achieves-100-percent-efficacy-in-china-trial/186004.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/new-parkinsons-drug-formulation-nearly-doubles-exposure/186014.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/fda-grants-first-approval-for-multiple-sclerosis-biosimilar/186040.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/revised-annex-1-now-effective/186056.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/pharmaceutical-migration-study-sampling-procedure-reported/186067.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-4-2023/186076.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/qa/qc-and-environmental-monitoring-in-depth-focus-2023/186080.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/bioprocessing-and-bioproduction-in-depth-focus-2023/186084.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sirna-therapy-shows-long-term-potential-in-lowering-ldl-c/186102.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/roche-subcutaneous-cancer-immunotherapy-granted-mhra-approval/186124.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/european-regulatory-perspective-on-nitrosamine-mitigation-strategies/186134.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-chemical-characterisation-and-databasing-at-medtronic/186138.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/developing-an-effective-contamination-control-strategy/186143.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/implementing-the-future-of-mrna-therapeutics/186159.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/how-breakthrough-car-t-cancer-therapies-could-be-made-more-widely-accessible/186170.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/leveraging-pat-for-environmental-monitoring-in-light-of-annex-1/186192.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/guidance-for-medicine-packaging-under-windsor-framework/186194.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/uncovering-new-frontiers-in-microbiology-and-em/186208.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/cgt-manufacturing-qc-market-to-value-28b-by-2031/186228.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/curbing-amr-through-sustainable-antibiotic-manufacturing/186251.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/stem-cell-therapy-delivers-potential-for-sickle-cell-disease/186261.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/chmp-recommends-updated-omicron-vaccine/186265.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/ima-the-all-in-one-solutions-provider-for-complete-vaccines-lines/186271.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/meeting-rising-demands-of-a-new-radiotheranostic-era/186284.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/2-billion-mrna-based-oncology-therapy-market-anticipated-by-2029/186297.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/trial-first-for-roche-lung-cancer-alk-inhibitor/186310.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/ftc-order-could-ease-biopharma-competition/186356.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-new-fabry-disease-treatment/186363.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/miniaturised-pat-tool-demonstrates-real-time-aggregation-measurement/186379.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/new-medicines-manufacturing-centre-to-enhance-uk-talent/186385.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/semaglutide-weight-loss-injection-launched-in-uk/186389.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/nitrosamines-the-beginning-of-the-end/186397.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/raman-spectroscopy-market-expected-to-value-875m-by-2028/186415.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/guidance-recommending-bms-cardiac-myosin-inhibitor-published/186426.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/horizon-europe-deal-signals-uk-research-reinvigoration/186447.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/alzheimers-senescent-cell-combination-therapy-presents-promise/186460.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-new-type-2-diabetes-treatment/186485.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/mhra-releases-its-cta-application-performance-metrics/186493.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/achieving-scale-up-success-under-economic-uncertainty/186502.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/technical-document-introducing-ami-polymers-sterile-sampling-systems/186549.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/the-benefits-of-mass-spectrometry-for-expediting-biologics-to-patients/186558.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/evaluating-nmr-relaxometry-for-antibody-identification/186572.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sandoz-to-commercialise-mab-biosimilar-candidate/186580.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/novel-strategy-could-facilitate-rapid-online-endotoxin-monitoring/186587.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/pioneering-pat-to-improve-gene-therapy-aav-manufacture/186595.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/novel-vaccine-delivers-significant-survival-in-lung-cancer-trial/186612.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/microbiome-therapy-manufacturing-facility-completed/186621.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/ai-to-revolutionise-drug-development-by-2026/186633.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/uk-atmp-facility-granted-cgmp-approval/186651.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/new-regulatory-relief-to-benefit-europes-pharma-smes/186660.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/msd-irelands-1b-facility-investment-achieves-new-milestone/186671.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/eu-tax-compliance-proposals-to-streamline-business-investment/186697.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-partnership-to-pioneer-uks-first-commercial-biomethane-supply/186705.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/pfizers-migraine-medicine-recommended-by-nice/186710.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/janssen-rebrands-its-identity/186733.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/small-molecule-drug-shows-promise-in-rare-disease/186742.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/cphi-pharma-awards-2023-finalists-announced/186746.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/guaranteeing-resilience-in-vaccine-manufacturing/186756.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/chmps-september-2023-meeting-highlights/186793.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/advanced-therapy-collaboration-network-launched-in-scotland/186799.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/first-treatment-for-myelofibrosis-with-anaemia-approved/186808.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/car-t-therapy-exhibits-encouraging-proficiency-in-r/r-lbcl/186815.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/european-commission-approves-long-acting-hiv-drug-option/186826.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/paving-the-way-for-anti-abeta-active-immunotherapy/186831.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/gene-therapy-a-radical-pharmaceutical-revolution/186848.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/the-european-commission-proposals-what-practical-impact/186866.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sa-mrna-vaccine-facilitates-durable-covid-19-immunisation/186871.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/new-manufacturing-facilities-to-enhance-bioconjugate-industry/186885.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/new-manufacturing-facility-could-drive-gold-standard-in-cell-therapy/186904.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/report-urges-for-new-pharma-standards-on-antimicrobials/186912.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/mhra-authorises-novel-pre-filled-pen-injector/186918.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/uk-rna-centre-of-excellence-opens/186949.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-eli-lilly-ulcerative-colitis-biologic/186954.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/aseptic-packaging-market-to-value-35bn-by-2033/186963.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/considerations-for-safety-data-migration-methods/186969.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/anti-pd-1-antibody-gains-eu-approval-for-oesophageal-cancer/187017.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/radioligand-therapy-demonstrates-novel-first-line-benefit/187026.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/achieving-pharmaceutical-drug-traceability-compliance/187036.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/first-multiple-sclerosis-biosimilar-approved-in-europe/187060.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/lymphoma-maintenance-therapy-delivers-promise-in-ctcl/187068.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/whitepapers/case-study-merck-streamlines-method-development/187077.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-accelerate-the-development-of-your-biologics/187081.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/webinar-advantages-bringing-early-phase-trials-to-north-america/187089.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/dmt-ssri-combination-shows-potential-for-depression/187098.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/european-pfas-restriction-could-jeopardise-pharmaceutical-manufacturing/187117.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/takeda-ulcerative-colitis-biologic-receives-fda-approval/187129.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/developing-point-of-care-car-t-manufacturing/187157.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/ai-supported-spectroscopy-delivers-superior-pharmaceutical-packaging-qc/187159.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/accelerating-amr-vaccine-development/187174.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/chemo-free-regimen-demonstrates-efficacy-in-nsclc/187184.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/cphi-barcelona-2023-event-preview/187189.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-first-in-class-antidepressant/187202.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/streamlining-bioprocessing-for-gene-therapy/187241.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/will-novel-antibiotic-become-front-line-for-c-difficile/187252.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/mrna-researchers-awarded-2023-nobel-prize/187262.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/ema-validates-maa-for-novel-telomerase-inhibitor/187271.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/sanofi-janssen-collaboration-to-advance-novel-e-coli-vaccine/187282.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/increasing-efficacy-in-extractables-and-leachable-testing/187305.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/who-recommends-second-malaria-vaccine/187311.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/lilly-agrees-14-billion-radiopharma-acquisition/187326.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/novartis-completes-sandoz-spin-off/187332.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/exploring-the-gene-therapy-biomanufacturing-landscape/187341.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sanofi-and-teva-to-develop-novel-ibd-treatment/187373.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/stem-cell-therapy-delivers-potential-in-alzheimers/187377.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/fujifilm-diosynth-recruits-new-quality-leader/187385.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/moderna-reveals-optimistic-data-for-influenza-covid-19-vaccine/187401.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/india-joins-mission-to-harmonise-pharmacopoeial-standards/187408.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/bristol-myers-squibb-agrees-nearly-6bn-oncology-merger/187445.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/msd-medicine-accepted-for-use-in-scotland/187453.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/novel-anti-epileptic-drug-demonstrates-efficacy/187461.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/life-sciences-innovation-day-accelerating-digital-transformation-ambition/187474.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/pharma-pushes-for-uk-medicine-scheme-revision/187484.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/ecnp-2023-new-esketamine-ns-safety-data-for-depression/187503.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/roche-multiple-sclerosis-subcutaneous-injection-late-breaking-data/187544.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/new-acquisition-to-accelerate-microbiome-therapeutics-manufacture/187551.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/mhra-regulation-overhaul-new-scheme-for-lowest-risk-uk-clinical-trials/187569.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/key-developments-in-pharmaceutical-manufacturing-september-2023/187590.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/research-predicts-2029-small-molecule-oncology-market-leaders/187604.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/whitepapers/technical-bulletin-streamline-your-drug-development-pathway-from-preclinic-to-fih/poc/187622.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-changing-regulatory-environment-for-nitrosamine-impurities/187627.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/follicular-lymphoma-btk-inhibitor-recommended-by-chmp/187633.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/study-reports-rapid-method-for-microbial-contaminant-detection/187642.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/lonza-to-enhance-commercial-antibody-drug-conjugate-supply-capacity/187684.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-agrees-13bn-hypertension-acquisition/187689.article 2026-04-17T09:26:41.370Z https://www.europeanpharmaceuticalreview.com/news/fda-issues-draft-guidance-on-alternative-tools-for-facility-assessments/187697.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-low-endotoxin-recovery-case-study/187698.article 2026-04-02T08:32:41.307Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-roche-biologic-for-lymphoma/187713.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-treatment-could-slow-type-1-diabetes-progression/187735.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-in-class-phosphate-absorption-inhibitor-approved-by-fda/187743.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sweden-gets-new-pharmaceutical-aseptic-filling-line/187753.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/targeting-tumours-with-novel-radiopharmaceuticals/187762.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/regulatory-first-for-gene-editing-therapy/187777.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/gaining-competitive-advantage-in-digital-quality-management/187795.article 2026-03-05T17:01:46.577Z https://www.europeanpharmaceuticalreview.com/news/eacs-2023-gilead-shares-real-world-evidence-for-biktarvy/187798.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/counterfeit-diabetes-pens-identified-in-eu-and-uk/187811.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/starvation-stress-key-in-micrococcus-luteus-cleanroom-survival/187836.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sustainability-crucial-for-pharmas-supply-chain-future/187841.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/could-eli-lilly-deliver-first-line-atopic-dermatitis-treatment/187849.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/roche-to-gain-rights-to-novel-antibody-for-ibd/187884.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/how-to-approach-die-plate-adhesion-during-tableting/187889.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/esmo-2023-janssen-reveals-data-for-intravesical-delivery-system/187904.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/sirna-drug-delivery-across-the-blood-brain-barrier-in-alzheimers/187911.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/europes-pharmaceutical-packaging-market-to-value-over-35bn-by-2028/187941.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/camfil/187946.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-the-importance-of-effective-dust-control-and-containment/187950.article 2026-03-12T16:09:59.143Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-selecting-dust-collection-equipment-for-tablet-presses/187959.article 2026-03-12T16:09:33.087Z https://www.europeanpharmaceuticalreview.com/news/approval-first-for-meningococcal-vaccine/187962.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cphi-selects-2023-pharma-award-winners/187979.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/guidance-on-machine-learning-enabled-medical-devices-published/187986.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/ebook-enhancing-impurity-control-with-data-management/187989.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-new-therapy-for-myelodysplastic-syndromes/188000.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sgs-isl-marks-two-year-anniversary/188008.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/video-gold-series-camtain-modular-dust-collection-system-for-pharmaceutical-applications/188014.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/antibody-drug-conjugates-paving-the-future-of-oncology-clinical-development/188042.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-first-parkinsons-treatment/188052.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uk-clinical-trial-application-submitted-for-amyloid-targeting-drug/188062.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/are-we-globally-prepared-for-the-next-pandemic/188070.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-bill-could-enhance-uk-clinical-trial-regulation/188091.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sustainable-biosimilar-competition-in-europe-can-it-be-achieved/188099.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gene-therapy-for-rare-muscular-dystrophy-presents-preliminary-promise/188110.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/mitigating-medicines-shortages-in-europe/188140.article 2026-03-06T16:31:07.623Z https://www.europeanpharmaceuticalreview.com/news/metformin-helps-manage-weight-gain-side-effect-of-sgas/188141.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/video-ami-polymer-setting-new-bioprocessing-standard/188165.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/weekly-injection-shows-promise-for-type-1-diabetes/188181.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-highly-efficient-method-development-for-analysis-of-oligonucleotides/188192.article 2026-03-11T10:56:46.640Z https://www.europeanpharmaceuticalreview.com/whitepapers/under-the-microscope-qc-compliance-and-environmental-isolates/188198.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/alfasigma-to-acquire-jyseleca-from-galapagos/188216.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/could-centrifugal-bioreactor-accelerate-cell-therapy-manufacturing/188233.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-approval-for-third-adapted-covid-19-vaccine/188237.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-5-2023/188246.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/qa/qc-and-microbiology-in-depth-focus-2023/188255.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/formulation-in-depth-focus-2023/188258.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/guide-to-outsourcing-2023/188261.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/challenging-applications-of-capillary-electrophoresis-in-biopharmaceutical-analysis/188265.article 2026-03-31T21:29:04.713Z https://www.europeanpharmaceuticalreview.com/news/antibiotics-no-longer-effective-for-childhood-infections-finds-study/188287.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-first-stelara-biosimilar-wezlana/188302.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/study-assesses-vaginal-film-for-hiv-prevention-/188331.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-authorises-alopecia-treatment/188336.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-unified-patent-court-assessing-the-impact-on-european-life-sciences-patent-litigation/188386.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/aao-2023-intravitreal-treatment-shows-benefit-in-geographic-atrophy/188396.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/global-cell-line-development-to-surge-in-next-decade/188408.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-authorises-new-treatment-for-rare-lung-cancer/188416.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gilead-reveals-positive-data-for-potential-first-line-adenocarcinoma-treatment/188429.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/rapid-hplc-method-could-improve-formulation-qc-studies/188457.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-insomnia-study-aims-to-overcome-major-clinical-trial-bottleneck/188463.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sandoz-and-teva-achieve-first-of-a-kind-manufacturing-certification/188515.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/developing-a-first-in-class-small-molecule-drug-for-inflammatory-disease/188533.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/targeted-therapy-for-hard-to-treat-leukaemia-subtype-approved-in-eu/188548.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-method-could-replace-microbiology-cfu-assay/188568.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/bioburden-and-sterility-testing-how-to-conserve-gene-therapy-product/188574.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/scientific-journal-complete-your-clinical-research-6-to-9-weeks-faster/188576.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-plans-multi-billion-denmark-manufacturing-expansion/188581.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/elevating-pharmaceutical-manufacturing-processes-with-real-time-insights/188595.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/news/first-chikungunya-vaccine-approved/188606.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-sirna-therapeutic-could-lower-cardiovascular-disease-risk/188712.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/could-gsk-myelofibrosis-treatment-gain-eu-first-approval/188724.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/advancing-clinical-development-in-haematology-oncology/188729.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/usp-general-chapter-glass-revised/188764.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/unified-vision-essential-in-uk-advanced-manufacturing/188772.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-acquisition-to-support-global-gene-therapy-manufacturing/188781.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-role-of-in-house-isolates-in-pharmaceutical-quality-control/188808.article 2026-03-10T09:47:16.797Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-led-illumination-a-win-win-for-microscopy-and-sustainability/188813.article 2026-03-25T11:46:35.827Z https://www.europeanpharmaceuticalreview.com/whitepapers/whitepaper-the-value-and-benefits-of-rapid-mold-detection-in-the-pharmaceutical-industry/188815.article 2026-03-10T09:52:35.220Z https://www.europeanpharmaceuticalreview.com/whitepapers/application-note-equivalency-of-pcr-based-rapid-sterility-testing-and-the-compendial-culture-method/188817.article 2026-03-10T09:52:35.220Z https://www.europeanpharmaceuticalreview.com/news/sandoz-mobilises-critical-medicine-production-in-europe/188831.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-recommends-new-immunotherapy-delivery-method/188841.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-future-of-osd-formulations/188845.article 2026-04-23T07:29:10.020Z https://www.europeanpharmaceuticalreview.com/news/chromatography-technique-developed-as-continuous-on-line-pat-tool/188867.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/trends-and-challenges-in-pharmaceutical-development/188874.article 2026-04-23T07:30:16.170Z https://www.europeanpharmaceuticalreview.com/news/first-crispr-based-gene-editing-therapy-authorised/188897.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/regional-inequalities-threatening-europes-biosimilars-market/188909.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/single-use-bioprocessing-market-to-value-8414bn-by-2032/188927.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/trial-for-novel-cgrp-migraine-medicine-gleans-positive-results/188950.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ec-approves-lebrikizumab-for-atopic-dermatitis/188962.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/mrna-therapies-a-new-frontier/188969.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/eu-pharma-legislation-key-in-tackling-amr/189029.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-reveals-plans-for-new-high-tech-parenteral-manufacturing-site/189040.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/brukinsa-granted-significant-eu-approval-in-follicular-lymphoma/189051.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsk-propels-its-progress-to-net-zero/189078.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fully-instrumented-3d-printed-small-scale-bioreactor-developed/189109.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ec-approves-first-line-ovarian-cancer-treatment/189113.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/digitalisation-and-pat-current-landscape-and-future-trends/189117.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/oligonucleotide-manufacturing-centre-to-open-in-scotland/189145.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/boehringer-ingelheim-to-advance-bacterial-cancer-therapeutics/189153.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/drug-development-trends-insight-from-thermo-fishers-anil-kane/189190.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/new-amgen-immunotherapy-could-treat-common-solid-tumour/189191.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/vertex-scores-european-cystic-fibrosis-medicine-approval/189207.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-to-expand-french-production-facilities/189219.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/long-covid-study-expanded-across-europe/189299.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-treatment-recommended-for-infants-with-wolman-disease/189307.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/could-stem-cell-therapy-stabilise-ms-progression/189321.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-pill-for-desmoid-tumours-approved/189348.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/nitrosamines-analysis-with-lc/ms-ms/189352.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/whitepapers/product-hub-choosing-the-right-tool-for-method-screening-and-process-optimisation/189353.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/cold-storage-market-to-value-383bn-by-2032/189377.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharma-unites-to-secure-renewable-energy-in-key-manufacturing-markets/189417.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/embracing-automation-in-sterile-manufacturing/189435.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/ferring-reveals-long-term-data-for-cancer-gene-therapy/189443.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/cell-and-gene-therapy-manufacturing-and-talent-trends-2023/189480.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/acquisition-deal-to-back-european-biosimilars-market/189492.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-technologies-facilitate-novel-contamination-detection-method/189510.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/abbvie-agrees-10-billion-oncology-acquisition/189524.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/survey-reports-on-falsification-of-medical-devices/189574.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novel-generalised-myasthenia-gravis-treatment-approved/189639.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharmaceutical-excipients-market-to-witness-expansion/189655.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/nk-cell-immunotherapy-whats-next-in-clinical-development/189678.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/phase-iii-data-for-novel-telomerase-inhibitor-released/189706.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/roche-to-advance-novel-obesity-and-diabetes-treatments/189713.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uks-entrance-into-horizon-europe-finalised/189723.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-secures-first-of-a-kind-haematology-approval/189735.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/whitepapers/under-the-microscope-scientifically-sustainable-endotoxin-testing-with-endosafe-trilliumandx2122-recombinant-cascade-reagent-rcr/189760.article 2026-03-06T11:20:12.063Z https://www.europeanpharmaceuticalreview.com/continuous-flow-chemistry-from-mrna-to-small-molecules/189764.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/antibody-immunotherapy-combination-shows-promise-in-lung-cancer/189790.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/understanding-the-evidence-used-in-drug-product-withdrawals/189810.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/common-drug-could-facilitate-huge-step-change-in-managing-type-1-diabetes/189831.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovation-first-mindset-vital-for-advanced-therapies-sector-future/189851.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/abbvie-to-buy-neuroscience-specialist-cerevel-therapeutics-for-87bn/189873.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/mhra-authorises-mounjaro-for-weight-management/189881.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ash-2023-microbiome-based-therapy-shows-potential-in-graft-versus-host-disease/189940.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/advancing-aocs-to-transform-the-delivery-of-rna-therapeutics/189952.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/gsk-immuno-oncology-treatment-achieves-novel-eu-approval/189965.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/year-in-review-eprs-top-stories-of-2023/189973.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-first-cell-based-gene-therapies-for-sickle-cell-disease/189985.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/construction-starts-on-400m-biosimilars-production-centre-in-slovenia/190000.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/europe-publishes-first-list-of-critical-medicines/190017.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ec-approves-treatment-for-rare-haematological-disorder/190025.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bms-agrees-84bn-adc-collaboration-with-systimmune/190037.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/new-approach-for-synthesis-of-oligonucleotide-conjugates/190062.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astellas-secures-ec-approval-for-vms-treatment-fezolinetant/190066.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/positive-results-for-mrna-vaccine-in-melanoma-patients/190101.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/alkermes-to-sell-irish-manufacturing-facility-to-novo-nordisk/190111.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chmp-issues-positive-option-for-first-gene-editing-medicine/190126.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/psilocybin-assisted-therapy-reduces-depressive-symptoms-in-cancer-patients/190166.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/260-million-funding-injection-for-danish-vaccines-initiative/190174.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-nitty-gritty-of-biotherapeutics-production/190220.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/european-regulators-prepare-for-ai-in-pharma/190240.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/otsuka-to-commercialise-hereditary-angioedema-drug-in-europe/190247.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-imperative-of-fridge-free-vaccines/190257.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/leveraging-innate-cell-engagers-for-lymphoma-treatment/190298.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/eu-pharmaceutical-legislation-revisions-what-are-the-implications-for-biopharma/190318.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/fda-grants-priority-review-to-omalizumab-for-food-allergies/190341.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nice-recommends-combination-therapy-for-prostate-cancer/190353.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/carbonated-water-makes-chromatography-more-environmentally-friendly/190359.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cdmo-expands-adc-facility-in-scotland/190365.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-stops-development-of-lung-cancer-drug/190370.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/meiragtx-sells-xlrp-gene-therapy-to-janssen/190385.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/trends-shaping-capsule-development/190392.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/biopharma-dealmaking-predictions-for-2024/190403.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/bms-strikes-14bn-deal-for-karuna-therapeutics/190416.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/webinars/contamination-control-strategies-how-to-achieve-faster-easier-process-monitoring/178879.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/cdpi-line-extension-with-capsule-based-inhalation-drug-delivery/179087.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/interphex-2023/180393.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/controlling-endotoxins-contamination-during-pharmaceutical-production/180606.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/lower-bioprocessing-costs-and-time-with-raman-spectroscopy/181037.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/2023-pda-parenteral-packaging-conference/181078.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/2023-pda-robotics-and-automation-conference/181223.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/benchtop-nmr-enhancing-pharmaceutical-development-scale-up-and-manufacturing/181225.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/the-hidden-costs-of-microbial-misidentifications/181609.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/mastering-regulatory-compliance-in-inventory-management-keys-for-success/181854.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/2023-pda-virus-conference/182871.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/2023-pda-biomanufacturing-conference/182878.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/2023-pda-universe-of-pre-filled-syringes-and-injection-devices-conference/182883.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/route-scouting-for-a-cost-effective-process-development/182896.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/strategies-for-implementing-econsent-across-the-european-regulatory-landscape/183030.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/determining-the-right-regulatory-pathway-for-your-drug/184508.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/implementing-continuous-flow-technologies-in-commercial-manufacturing/185319.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/analysis-of-impurities-in-pharmaceuticals-using-ion-chromatography/185333.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/advantages-of-automated-microbial-colony-counting/185756.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/gaining-competitive-advantage-in-digital-quality-management/186011.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/pharma-microbiology-navigating-compliance-and-best-practices/186483.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/rmms-and-endotoxin-testing-efficiency-gains-and-regulatory-perspectives/186648.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/barcelona-breakfast-briefing-how-is-pharma-40-shaping-manufacturing/186695.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/accelerate-shop-floor-productivity-in-pharma-with-paperless-manufacturing/187283.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/how-to-implement-single-temperature-incubation-in-your-environmental-monitoring-routine/187525.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/navigating-challenges-in-hpapi-development-and-manufacturing/187570.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/webinars/solve-your-dosage-form-and-delivery-challenges-with-lonza-capsule-application-lab/189626.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/aaps-national-biotechnology-conference/190213.article 2026-03-29T18:53:27.433Z